Ingredion (INGR) is a bit shy of elite status by IBD standards. After a weak 2009, the company grew earnings 61% and 45% in 2010-11. The Street expects EPS growth to come in at 18% for 2012. Research shows that elite stocks have annual EPS growth of at least 25% in each of the past three years. So, if 2012 results meet or miss views, they'll fall short of the mark. The company will release Q4 and full-year results before the market opens on Feb.